These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 37503751)

  • 1. Pruritus burden assessment in severe atopic dermatitis patients under dupilumab: response predictor?
    Brás R; Limão R; Pedro E; Lopes A
    Eur Ann Allergy Clin Immunol; 2023 Jul; ():. PubMed ID: 37503751
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and Risk Stratification of Janus Kinase Inhibitors in the Treatment of Moderate-to-Severe Atopic Dermatitis.
    Narla S; Silverberg JI
    Dermatitis; 2024; 35(S1):S24-S38. PubMed ID: 37527229
    [No Abstract]   [Full Text] [Related]  

  • 3. Effectiveness and safety of upadacitinib in patients with face and neck atopic dermatitis unresponsive to dupilumab.
    Yang Y; Chen J; Yu N; Ke Y; Gao A; Xiong S; Zhao X; Liu Y; Zhu H
    J Dermatolog Treat; 2023 Dec; 34(1):2242540. PubMed ID: 37526019
    [No Abstract]   [Full Text] [Related]  

  • 4. Atopic dermatitis and ocular allergy: common mechanisms and uncommon questions.
    Ghosh D; Mersha TB
    Curr Opin Allergy Clin Immunol; 2023 Oct; 23(5):383-389. PubMed ID: 37527055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study.
    Kimball AB; Delevry D; Yang M; Chuang CC; Wang Z; Bégo-Le-Bagousse G; Martins B; Wu E; Shumel B; Wang J; Sierka D; Chao J; Strober B
    Dermatol Ther (Heidelb); 2023 Sep; 13(9):2107-2120. PubMed ID: 37552431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety profile of dupilumab for the treatment of atopic dermatitis in children and adolescents: A systematic review and meta-analysis.
    Xu Y; Guo L; Li Z; Wu S; Jiang X
    Pediatr Dermatol; 2023; 40(5):841-850. PubMed ID: 37529963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in immunomodulators for atopic dermatitis.
    Yim HJ; Jean T; Ong PY
    Curr Opin Pediatr; 2023 Dec; 35(6):671-679. PubMed ID: 37522635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multimodal initiative improves general pediatric provider management of atopic dermatitis in children: A prospective interventional study.
    Lee SS; Kaushik A; Natsis N; Kusari A; Schairer D; Lindback S; Levenberg M; Mills JR; Peeples K; Smith R; Eichenfield LF
    J Am Acad Dermatol; 2023 Nov; 89(5):1041-1044. PubMed ID: 37516950
    [No Abstract]   [Full Text] [Related]  

  • 9. Concomitant use of dupilumab with glucocorticoid in bullous pemphigoid reduces disease severity: A preliminary study.
    Hu L; Huang R; Jiang F; You S; Wu Q
    Immun Inflamm Dis; 2023 Jul; 11(7):e924. PubMed ID: 37506153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2 chronic inflammatory diseases: targets, therapies and unmet needs.
    Kolkhir P; Akdis CA; Akdis M; Bachert C; Bieber T; Canonica GW; Guttman-Yassky E; Metz M; Mullol J; Palomares O; Renz H; Ständer S; Zuberbier T; Maurer M
    Nat Rev Drug Discov; 2023 Sep; 22(9):743-767. PubMed ID: 37528191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: Results from a phase 2b, randomized, controlled trial.
    Guttman-Yassky E; Silverberg JI; Thaçi D; Papp KA; Ständer S; Beck LA; Kim BS; Hu X; Liu J; Calimlim BM; Vigna N; Crowley JT; Teixeira HD; Thyssen JP
    J Eur Acad Dermatol Venereol; 2023 Dec; 37(12):2558-2568. PubMed ID: 37528500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell profiling of prurigo nodularis demonstrates immune-stromal crosstalk driving profibrotic responses and reversal with nemolizumab.
    Ma F; Gharaee-Kermani M; Tsoi LC; Plazyo O; Chaskar P; Harms P; Patrick MT; Xing X; Hile G; Piketty C; Lazzari A; Van Delm W; Maverakis E; Nakamura M; Modlin RL; Kahlenberg JM; Billi AC; Julia V; Krishnaswamy JK; Gudjonsson JE
    J Allergy Clin Immunol; 2024 Jan; 153(1):146-160. PubMed ID: 37506977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A real-world Australian experience of upadacitinib for the treatment of severe atopic dermatitis.
    Tran V; Ross G
    Australas J Dermatol; 2023 Nov; 64(4):e352-e356. PubMed ID: 37525472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of nemolizumab in paediatric patients aged 6-12 years with atopic dermatitis with moderate-to-severe pruritus: results from a phase III, randomized, double-blind, placebo-controlled, multicentre study.
    Igarashi A; Katsunuma T; Matsumura T; Komazaki H;
    Br J Dermatol; 2023 Dec; 190(1):20-28. PubMed ID: 37522351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiota and IL-33/31 Axis Linkage: Implications and Therapeutic Perspectives in Atopic Dermatitis and Psoriasis.
    Bonzano L; Borgia F; Casella R; Miniello A; Nettis E; Gangemi S
    Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retreatment with upadacitinib in atopic dermatitis: experience in clinical practice.
    Martínez-Fernández S; Suh-Oh HJ; Batalla A; Couselo-Rodríguez C; Espasandín-Arias M; Flórez Á
    J Dermatolog Treat; 2023 Dec; 34(1):2242543. PubMed ID: 37528806
    [No Abstract]   [Full Text] [Related]  

  • 17. Challenges and Future Trends in Atopic Dermatitis.
    Gatmaitan JG; Lee JH
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fc Epsilon RI-Neuroimmune Interplay in Pruritus Triggered by Particulate Matter in Atopic Dermatitis Patients.
    Isaifan D; Crovella S; Soubra L; Al-Nesf M; Steinhoff M
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a novel microneedle platform for biomarker assessment of atopic dermatitis patients.
    Lee KH; Kim JD; Jeong DH; Kim SM; Park CO; Lee KH
    Skin Res Technol; 2023 Jul; 29(7):e13413. PubMed ID: 37522507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The methylation profile of
    Gorzkiewicz M; Łoś-Rycharska E; Gawryjołek J; Gołębiewski M; Krogulska A; Grzybowski T
    Front Immunol; 2023; 14():1209190. PubMed ID: 37520545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.